Federal Appeals Court Puts Chill On Maryland Law To Fight Drug Price-Gouging

April 19, 2018

States continue to battle budget-busting prices of prescription drugs. But a federal court decision could limit the weapons available to them — underscoring the challenge states face as they, in the absence of federal action, go one-on-one against the powerful drug industry. The 2-to-1 ruling Friday by the U.S. 4th Circuit Court of Appeals invalidated […]

Certara Acquires Analytica Laser, a Leader in Market Access, Health Economics and Outcomes Research (HEOR), and Real-world Evidence Solutions

April 12, 2018

Acquisition adds real-world effectiveness prediction and value assessment to Certara’s model-informed drug development and regulatory science decision-making portfolio Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has acquired Analytica Laser, a global research consultancy that uses health economics and outcomes research (HEOR) and real-world data to provide the […]

CVS’ Caremark Customers Now Have A Tool That Makes It Easier To Find Less Expensive Drugs

April 12, 2018

The drugstore chain is introducing a system that will check for less expensive alternatives, higher quantities at lower costs and discounts. CVS hopes it can help lower costs for its customers and in doing so, make sure they pick up their prescriptions. Drug costs are rising, and patients are paying more of their health-care bills […]

Why We May Lose Generic Drugs

April 12, 2018

The mood at the annual generic drug industry confab in Orlando in February was especially somber. The discussion during one panel was all about plunging drug prices, consolidation among drug-buying groups, and the increasingly cutthroat nature of the business. A top executive at Israel-based Teva Pharmaceutical Industries Ltd., the No. 1 supplier of generics in the […]

AcelRx Announces Publication Analyzing the Cost of Administering IV Morphine for Acute Pain in Emergency Departments in Europe

April 12, 2018

REDWOOD CITY, Calif., April 11, 2018 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported the publication of a report commissioned by AcelRx analyzing the economic burden associated with administration of intravenous (IV) morphine for acute […]

Britain’s Use Of Copycat Biotech Drugs Takes Off While U.S. Lags

March 22, 2018

LONDON (Reuters) – Cut-price copies of an expensive Roche biotech drug for blood cancer have taken 80 percent of the British market since launching last year, saving the healthcare system 80 million pounds ($113 million) a year, experts said on Wednesday.   The rapid adoption of two so-called biosimilar forms of rituximab from Celltrion and […]

Hepatitis C Drugs Save Lives, but Sick Prisoners Aren’t Getting Them

March 15, 2018

Any national campaign to eliminate hepatitis C, an insidious virus that kills tens of thousands of Americans a year, would almost certainly involve prisons. One in seven state inmates are believed to be infected, and the regimented environment of a prison has its advantages when it comes to screening and treatment. The problem is, the […]

Regeneron and Sanofi Announce Plans to Make Praluent® (alirocumab) More Accessible and Affordable for Patients with the Greatest Health Risk and Unmet Need

March 12, 2018

TARRYTOWN, N.Y. and PARIS, March 10, 2018 /PRNewswire/ — To help ensure more affordable and timely access to patients most in need, Regeneron Pharmaceuticals (NASDAQ: REGN) and Sanofi will offer payers that agree to reduce burdensome access barriers for high-risk patients a further reduced net price for Praluent® (alirocumab) Injection, in alignment with a new […]

Two Labs Acquires MKO Global Partners

February 8, 2018

FOR IMMEDIATE RELEASE Media Contact: Alexis Marina 330-519-6892   Two Labs Acquires MKO Global Partners Company expands presence in the pharma consulting space with the addition of pricing and payer strategy services COLUMBUS, Ohio (February 8, 2018) – Two Labs, an industry-leading pharma and life science services company, today announced that it has acquired MKO […]

Vizient Releases New Drug Price Forecast for 2018-2019: Price Increases Slow, But Challenges Remain

January 29, 2018

IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. has released its January 2018 Drug Price Forecast and estimates that for pharmaceutical purchases made from July 1, 2018 to June 30, 2019, health systems can expect a 7.35 percent increase. An executive summary of the Drug Price Forecast can be accessed here.   .@vizientinc releases its January 2018 #Drug Price […]

Spark prices its gene therapy as most expensive U.S. medicine — but with plans to ease cost concerns

January 4, 2018

Spark Therapeutics priced Luxturna, a gene therapy for a rare form of blindness, at $850,000.   The first gene therapy in the U.S., approved last month to treat a rare, inherited form of blindness, now has a price tag: $850,000.   That makes the treatment, called Luxturna and made by Spark Therapeutics, the most expensive […]

The California Co-Pay Conundrum

January 2, 2018

TrialCard Addresses AB 265 On October 9, 2017, California Governor Jerry Brown signed AB 265 into law. This landmark piece of legislation modified the California Health and Safety Code to prohibit the “offering” of any discount, product voucher, or other out-of-pocket cost reduction tool by drug manufacturers when there is an FDA-approved therapeutic equivalent. As […]

Gilead Launches Hep C Drug Sovaldi in China at One-Fifth of U.S. Price

November 30, 2017

Gilead has officially launched its hepatitis C drug Sovaldi (sofosbuvir) in the Chinese market, but with one major caveat: it will cost 58,980 yuan ($8,937) in the region, just one-fifth of its price tag in the US – a price which has fallen rapidly from the $84,000 it originally launched at.   There are around […]

2018 Healthcare Predictions

November 29, 2017

Every year, InCrowd surveys physicians across a wide range of specialties to better understand their perspective on healthcare policies and trends, and learn what they think will happen in the year ahead. Join us as we take a look at physician predictions and insights for 2018, and how they compare to years past. In the […]